XML 35 R24.htm IDEA: XBRL DOCUMENT v3.25.3
SALES (Tables)
 9 Months Ended
Sep. 26, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Contract Liabilities
Our contract liabilities consisted of the following ($ in millions):
September 26, 2025December 31, 2024
Deferred revenue - current$415.0 $410.1 
Deferred revenue - noncurrent21.1 23.1 
Total contract liabilities$436.1 $433.2 
Schedule of Remaining Performance Obligations
The aggregate remaining performance obligations attributable to each of our segments is as follows ($ in millions):
September 26, 2025
Intelligent Operating Solutions$701.2 
Advanced Healthcare Solutions109.4 
Total remaining performance obligations$810.6 
Schedule of Disaggregation of Revenue
Disaggregation of revenue for the three months ended September 26, 2025 is presented as follows ($ in millions):
TotalIntelligent Operating SolutionsAdvanced Healthcare Solutions
Sales:
Sales of products and software$814.4 $557.4 $257.0 
Sales of services212.7 141.4 71.3 
Total$1,027.1 $698.8 $328.3 
Geographic:
North America (a)
$624.7 $433.2 $191.5 
Asia-Pacific
181.4 111.4 70.0 
Europe, Middle East, and Africa
167.9 126.3 41.6 
Latin America
53.1 27.9 25.2 
Total
$1,027.1 $698.8 $328.3 
End markets:
Healthcare$322.2 $10.8 $311.4 
Industrial & Manufacturing287.9 284.3 3.6 
Energy & Infrastructure166.7 166.7 — 
Government88.0 78.1 9.9 
Retail82.7 82.7 — 
Other79.6 76.2 3.4 
Total$1,027.1 $698.8 $328.3 
(a) North America is comprised of the United States and Canada. Sales attributed to the United States were 57% of total Fortive sales.
Disaggregation of revenue for the three months ended September 27, 2024 is presented as follows ($ in millions):
TotalIntelligent Operating SolutionsAdvanced Healthcare Solutions    
Sales:
Sales of products and software$802.5 $549.1 $253.4 
Sales of services201.2 132.2 69.0 
Total$1,003.7 $681.3 $322.4 
Geographic:
North America (a)
$601.7 $412.8 $188.9 
Asia-Pacific
177.8 109.1 68.7 
Europe, Middle East, and Africa
168.1 129.5 38.6 
Latin America
56.1 29.9 26.2 
Total
$1,003.7 $681.3 $322.4 
End markets:
Healthcare
$315.5 $10.6 $304.9 
Industrial & Manufacturing
282.7 278.5 4.2 
Energy & Infrastructure157.5 157.5 — 
Government93.0 82.9 10.1 
Retail75.3 75.3 — 
Other79.7 76.5 3.2 
Total$1,003.7 $681.3 $322.4 
(a) North America is comprised of the United States and Canada. Sales attributed to the United States were 57% of total Fortive sales.
Disaggregation of revenue for the nine months ended September 26, 2025 is presented as follows ($ in millions):
TotalIntelligent Operating SolutionsAdvanced Healthcare Solutions    
Sales:
Sales of products and software$2,431.6 $1,688.9 $742.7 
Sales of services605.0 397.7 207.3 
Total$3,036.6 $2,086.6 $950.0 
Geographic:
North America (a)
$1,827.3 $1,269.7 $557.6 
Asia-Pacific
542.3 338.4 203.9 
Europe, Middle East, and Africa
516.4 394.8 121.6 
Latin America
150.6 83.7 66.9 
Total
$3,036.6 $2,086.6 $950.0 
End markets:
Healthcare$931.8 $32.4 $899.4 
Industrial & Manufacturing874.9 862.3 12.6 
Energy & Infrastructure499.8 499.8 — 
Government262.0 234.1 27.9 
Retail229.5 229.5 — 
Other238.6 228.5 10.1 
Total$3,036.6 $2,086.6 $950.0 
(a) North America is comprised of the United States and Canada. Sales attributed to the United States were 57% of total Fortive sales.
Disaggregation of revenue for the nine months ended September 27, 2024 is presented as follows ($ in millions):
TotalIntelligent Operating SolutionsAdvanced Healthcare Solutions    
Sales:
Sales of products and software$2,420.1 $1,679.2 $740.9 
Sales of services588.0 383.1 204.9 
Total$3,008.1 $2,062.3 $945.8 
Geographic:
North America (a)
$1,769.4 $1,224.8 $544.6 
Asia-Pacific
549.4 346.7 202.7 
Europe, Middle East, and Africa
529.0 407.1 121.9 
Latin America
160.3 83.7 76.6 
Total
$3,008.1 $2,062.3 $945.8 
End markets:
Healthcare$927.4 $33.5 $893.9 
Industrial & Manufacturing871.8 858.4 13.4 
Energy & Infrastructure484.5 484.5 — 
Government263.8 235.3 28.5 
Retail212.4 212.4 — 
Other248.2 238.2 10.0 
Total$3,008.1 $2,062.3 $945.8 
(a) North America is comprised of the United States and Canada. Sales attributed to the United States were 55% of total Fortive sales.